CCCC
C4 Therapeutics Inc

2,331
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 06,
Pre-Market

Estimated EPS

-$0.41

Estimated Rev

$6.28M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.41
--
--
N/A
Q2 '25
-$0.38
-$0.37
3.65%
BEAT
Q1 '25
-$0.44
-$0.37
16.29%
BEAT
Q4 '24
-$0.49
-$0.49
0.62%
BEAT
Q3 '24
-$0.38
-$0.35
7.64%
BEAT

Latest CCCC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.